[Prevention of recurrent calcic nephrolithiasis with thiazides. Clinico-metabolic evaluation].
D000584:Amiloride / Q000627:therapeutic use; D002118:Calcium / Q000652:urine; D004232:Diuretics; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006934:Hypercalcemia / Q000139:chemically induced; D007669:Kidney Calculi / Q000517:prevention & control*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D000584:Amiloride; D002118:Calcium
Profilassi della nefrolitiasi calcica recidivante (NCR) con tiazidici. Valutazioni clinico-metaboliche.